About Hezongyy
Hezongyy is a publicly listed company based in Chengdu (China) founded in 2010. Online pharmacy services for various diseases are provided. Its focus areas include HealthTech, Healthcare Booking Platforms, Pharmacies and Drugs. Similar companies include 111 Group, Shanghai Pharmaceutical and 7LK; 3 of its 3 listed similar companies have raised funding.
Company details
Hezong Medicine was founded in 2010 in Chengdu, China, as a provider in the healthcare sector. An online platform is operated to facilitate purchases of medicines addressing respiratory conditions, generic drugs, digestive issues, skin disorders, gynecology, cardiovascular problems, endocrine systems, and additional categories. Operations emphasize digital access to pharmaceuticals for multiple disease areas.
- Headquarters Chengdu, China
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website hezongyy.com
- Legal Name Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Co., Ltd. Class A
- Annual Revenue$635.62 M (USD)1.34as on Dec 31, 2025
- Net Profit-$1.84 M (USD)-197.36as on Dec 31, 2025
- EBITDA$8.37 M (USD)-6.25as on Dec 31, 2025
IPO & Listings of Hezongyy
Hezongyy is a publicly listed company on the SZSE with ticker symbol 300937 in China, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date27 Jan 2021
- Listed onSZSE: 300937
- Listed entitySichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Class A
- Exchange sectorTechnology services
- ISINCNE100004CV9
- Share price23.10 CNY (-2.86% on the day) · 2026-10-14
- Market capitalisation2,274,953,701.00 CNY
- EPS (diluted, trailing year)-0.15 CNY
- Dividend yield0.43%
- Volume (last session)1,459,600
Financials of Hezongyy
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 4.45B CNY | -12.8M CNY | 58.6M CNY |
| 2024 | 4.39B CNY | 13.2M CNY | 62.5M CNY |
| 2023 | 4.43B CNY | 59.5M CNY | 101.2M CNY |
| 2022 | 3.97B CNY | 42.0M CNY | 78.6M CNY |
| 2021 | 3.40B CNY | 6.4M CNY | 16.4M CNY |
Detailed financial statements for Hezongyy
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Hezongyy
Hezongyy has 3 listed similar companies in our database, 3 of them funded. They include 111 Group, Shanghai Pharmaceutical and 7LK.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 111.com.cn | 2010 | Guangzhou, China | $122M | Online pharmacy for selling pharmaceuticals and health products | ||
| sphcchina.com | 2015 | Shanghai, China | $228.18M | Provider of a cloud-based mobile app for purchasing medicines online | ||
| 7lk.com | 2011 | Guangzhou, China | $48M | Non-prescription drugs and health supplements are retailed online by 7LK. |
Detailed similar companies of Hezongyy
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hezongyy
Complete news archive for Hezongyy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hezongyy
Hezongyy was founded in 2010.
Hezongyy is headquartered in Chengdu, China. It is registered at Chengdu, Sichuan, China.
Annual revenue of Hezongyy is $635.62M as on Dec 31, 2025.
Hezong Medicine was founded in 2010 in Chengdu, China, as a provider in the healthcare sector. An online platform is operated to facilitate purchases of medicines addressing respiratory conditions, generic drugs, digestive issues, skin disorders, gynecology, cardiovascular problems, endocrine systems, and additional categories. Operations emphasize digital access to pharmaceuticals for multiple disease areas.
Hezongyy's top competitors include 111 Group, Shanghai Pharmaceutical and 7LK.
Yes, Hezongyy is publicly traded on SZSE under the ticker symbol 300937.